Similarly to p53 tumor suppressor context, LKB1-KD or AMPK-KD decreased YAP phosphorylation and subsequently abolished DVL’s ability to suppress nuclear YAP abundance and TEAD transcriptional activity (Fig. 7c and Supplementary Fig. 9b). Here, DVL1 is linked to neoplasm.